Long Term Follow-up of Persistent Pain, Sensory Disturbances and Lymphedema After Breast Cancer Treatment
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,411
- 试验地点
- 1
- 主要终点
- Prevalence of persistent pain
研究概览
简要总结
Persistent pain, sensory disturbances, lymphedema and functional impairment are frequently occurring late effects of breast cancer treatment. The investigators have previously published data on 3253 women treated for breast cancer in Denmark in the period 2005-2006. Very few studies have examined how these late effects change in time. The aim of this study is to examine in a well defined patient population any change in the prevalence of persistent pain, sensory disturbances, lymphedema and functional impairment, as well as risk factor profile.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Diagnosed with primary breast cancer between 2005-2006
- •Participated in a study in 2008
排除标准
- •Recurrent or new primary cancer
- •Metastatic cancer
- •Reconstructive surgery
结局指标
主要结局
Prevalence of persistent pain
时间窗: 6-7 years post operative
Prevalence of pain in the breast area, axilla, side of chest or arm, as a yes/no variable
Prevalence of patients changing pain status from the 2008 survey
时间窗: 6-7 years
次要结局
- Prevalence of sensory disturbance(6-7 years)
- Prevalence of self reported lymphedma(6-7 years)
- Prevalence of functional impairment(6-7 years)
- Risk factors associated for persistent pain, sensory disturbances, lymphedema or functional impairment(6-7 years)
- Prevalence of patients changing status of sensory disturbances and self reported lymphedma(6-7 years)
- Risk factors associated to changing status of sensory disturbances and lymphedema(6-7 years post operative)
研究者
Kenneth Geving Andersen
MD
Rigshospitalet, Denmark